# Final production readiness report

Date: **2026-05-07**

Scope: final stabilization verification for TypeScript, ESLint, package scripts, documentation, Docker assets, environment variables, security/auth/database/AWS/local/testing docs, README links, internal documentation links, TODO/MVP limitations, secret exposure, placeholder safety, mock-data documentation, and build readiness. This pass intentionally avoids new product features and does not change UI styling.

## Final readiness score

**82 / 100**

Sihati has a strong production-oriented foundation: lint/typecheck/tests/build pass, runtime environment validation exists, Docker assets are present, documentation coverage is broad, mock/provider placeholders are documented, and production runtime fail-fast behavior exists for critical configuration. The score is not higher because the current MVP still has deployment blockers around real production authentication, payment/webhook implementation, database-backed replacement of demo pages/placeholders, shared rate limiting, production infrastructure execution, and broader integration/E2E coverage.

## Verification summary

| Area | Status | Notes |
| --- | --- | --- |
| TypeScript consistency | Pass | `npm run typecheck` completed successfully. |
| ESLint consistency | Pass | `npm run lint` completed successfully. |
| Unit/API tests | Pass | `npm test` completed successfully with 13 files and 49 tests passing. |
| Build readiness | Pass | `npm run build` completed successfully with Next.js standalone output. |
| Dependency audit | Pass | `npm audit --audit-level=moderate` found 0 vulnerabilities. |
| Package scripts | Improved | Added `audit:prod` and `prod:check` scripts for a single release-candidate gate. |
| Documentation completeness | Pass with known MVP gaps | Core docs exist for security, auth, database, AWS deployment, Docker, local install, local testing, service configuration, maintenance, deployment, and production checklist. |
| README links | Pass | Internal file and anchor links were checked after documentation updates. |
| Broken internal documentation links | Pass | No broken Markdown file links or local anchors were found. |
| Docker files | Present, partially environment-limited | `Dockerfile` and `docker-compose.yml` are present. Docker CLI is unavailable in this environment, so compose/build execution could not be performed here. |
| Environment variables | Improved | `.env.example` now includes operational runtime defaults used by Docker/standalone deployments. Production-required secrets remain documented and validated. |
| Security docs | Pass with blockers documented | Security hardening and production fail-fast policy are documented. Remaining auth/rate-limit/provider blockers are explicit. |
| Auth docs | Pass with blocker | Authentication architecture is documented, but demo-header auth must be replaced before production. |
| Database docs | Pass with blocker | Prisma schema/repositories and deployment options are documented, but production migration/restore validation remains required. |
| AWS deployment docs | Pass | AWS deployment guide and production checklist exist and cover secrets, networking, HTTPS, backups, monitoring, and release gates. |
| Local installation docs | Pass | GitHub/local installation and local testing guides exist. |
| Testing docs | Improved | Testing docs now mention the production release-candidate script and dependency audit stage. |
| TODOs and MVP limitations | Pass with blockers documented | MVP placeholders and mock fallbacks are documented and isolated, with production fail-fast behavior for database-dependent API fallback paths. |
| Accidental exposure of secrets | Pass | Secret scan found only documented/test placeholder values, not real private keys or live credentials. |
| Unsafe placeholder code | Pass with blockers | High-risk provider routes return explicit `501` responses or require secrets/signature checks rather than returning success-like fake behavior. Remaining placeholders are release blockers where they touch real production workflows. |
| Mock data documentation | Pass | Mock repositories, demo pages, and MVP placeholders are documented in README and stabilization docs. |

## Completed items in this pass

- Ran TypeScript, ESLint, unit/API test, production build, dependency audit, internal Markdown link, Markdown anchor, secret-pattern, and TODO/MVP-placeholder verification.
- Confirmed `npm run lint`, `npm run typecheck`, `npm test`, `npm run build`, and `npm audit --audit-level=moderate` pass.
- Added release-candidate package scripts:
  - `npm run audit:prod`
  - `npm run prod:check`
- Updated README references so the current final production readiness report is linked from the documentation package and final audit area.
- Updated testing documentation to include the production release-candidate gate and dependency audit stage.
- Expanded `.env.example` with operational runtime defaults for Next telemetry, standalone port, and hostname.
- Created this report with readiness score, completed checks, blockers, remaining risks, monitoring/backup guidance, MVP limitations, and file-change inventory.

## Remaining risks

1. **Production authentication is not implemented yet.** Demo-header auth is isolated and disabled in production, but production must use Firebase Auth, JWT verification, or signed session cookies before release.
2. **Shared rate limiting is not implemented yet.** The current in-memory limiter is acceptable for local/single-process MVP use only and must be replaced for horizontally scaled production.
3. **Payment and webhook flows are placeholders.** Stripe checkout and webhook endpoints must be implemented with signature verification, idempotency, payment state transitions, and tests before accepting real payments.
4. **Some user-facing flows still use demo/sample data.** Dashboard, consultation, and booking-success data must be database-backed and resource-authorized before production launch.
5. **Database production migration workflow still needs release validation.** Prisma schema exists, but production migrations, seed strategy, rollback approach, and restore drills must be tested against staging/production-like infrastructure.
6. **Integration/E2E coverage remains limited.** Current tests are strong for validators, services, auth helpers, security helpers, and selected API contracts, but not yet full end-to-end production workflow coverage.
7. **Docker execution could not be verified in this environment.** Docker files are present, but Docker CLI is unavailable here; image build and compose validation must run in CI or another environment with Docker installed.
8. **Medical data compliance controls need final review.** Before production, confirm privacy, retention, audit logging, storage encryption, access controls, and incident-response requirements for the intended regulatory scope.

## Deployment blockers

Production deployment should **not** proceed until these are resolved:

- Replace demo-header authentication with a verified production auth provider/session implementation.
- Replace in-memory rate limiting with a shared production limiter.
- Configure production database, run reviewed Prisma migrations, and verify backup/restore procedures.
- Replace remaining database-relevant demo/sample data in protected user workflows.
- Implement or explicitly disable production payment collection with verified Stripe checkout/webhook behavior.
- Configure real provider secrets through a secret manager; do not use `.env.example` or Docker placeholder values in production.
- Run Docker image build/compose checks in an environment with Docker available.
- Add staging smoke tests and at least one authenticated production-like path validation before release.

## Recommended next actions before production

1. Implement production authentication in `lib/auth/session.ts` while preserving centralized current-user and role checks.
2. Add integration tests for patient, practitioner, and admin authorization paths across protected APIs and pages.
3. Promote Prisma migrations through staging, validate rollback/forward-fix procedures, and document restore evidence.
4. Replace dashboard, consultation, booking-success, medical-document, review, payment, and notification placeholders with database/provider-backed implementations or keep them explicitly disabled for production scope.
5. Add a shared rate limiter such as Redis, Upstash, Cloudflare, or a load-balancer/WAF policy.
6. Run `npm run prod:check` in CI and keep each stage visible as separate jobs for diagnostics.
7. Run Docker image build and compose validation in CI with Docker available.
8. Perform a pre-launch security review focused on auth, authorization, secrets, logs, medical data privacy, upload handling, and provider webhooks.

## Recommended monitoring and backup plan

### Monitoring

- Application health: uptime checks for `/`, search, booking entry, and protected route redirects.
- API health: alert on elevated 4xx/5xx rate, validation-error spikes, auth failures, rate-limit events, and webhook failures.
- Performance: track server response latency, Next.js route timing, database query latency, and slow pages.
- Security: alert on repeated auth failures, suspicious same-origin failures, unexpected 501 route hits in production, and access-denied spikes.
- Infrastructure: monitor CPU, memory, disk, container restarts, load-balancer target health, TLS certificate expiry, and DNS health.
- Business flow: monitor appointment creation, notification dispatch, payment state transitions when implemented, and practitioner availability lookup failures.

### Backup and recovery

- Use automated daily database backups with point-in-time recovery where available.
- Retain backups according to privacy/compliance requirements and document retention periods.
- Encrypt backups at rest and restrict restore permissions to approved operators.
- Test restore procedures in staging before production launch and at regular intervals afterward.
- Keep infrastructure configuration and deployment runbooks versioned.
- Define recovery time objective (RTO), recovery point objective (RPO), incident ownership, and escalation contacts before launch.

## MVP limitations still present

- Demo-header auth remains the local/test adapter and is not production authentication.
- Practitioner search and availability can use local mock fallback only when no database is configured outside production.
- Medical documents, reviews, Stripe checkout, and Stripe webhook endpoints are not full production implementations.
- Video consultation, booking success, and dashboard sample-data flows still need database-backed, resource-authorized implementations.
- Email notification sending is currently MVP console/provider-adapter oriented and needs production provider hardening, retries, failure handling, and observability.
- Integration, E2E, and production-like database transaction tests are not yet complete.
- Docker image/compose execution needs CI validation because Docker was unavailable in this environment.

## File inventory for this pass

### Created files

- `docs/final-production-readiness-report.md`

### Modified files

- `.env.example`
- `README.md`
- `docs/testing.md`
- `package.json`

### Deleted files

- None

## Final summary

The repository is substantially stabilized and operationally documented, with passing local quality gates and a clearer release-candidate script. It is **not yet approved for live production traffic** because production authentication, shared rate limiting, provider/payment hardening, production database migration/backup validation, Docker CI execution, and database-backed replacement of remaining MVP placeholders are still required. The next phase should focus only on those release blockers and operational validations, without changing UI style or adding unrelated features.
